Business Wire

Corona and Parley for the Oceans Launch Creative Fundraising Platform “Clean Waves” to Fight Marine Plastic Pollution

Share

Today, Corona and Parley for the Oceans announce the evolution of their partnership: Clean Waves, a creative fundraising platform aimed at boosting the use of eco-innovative materials in fashion and industrial design. The first product launched, sunglasses, are made from Parley Ocean Plastic® and incorporate new forms of upcycled marine debris intercepted on islands, coastal communities, beaches, underwater and on high seas. The limited-edition sunglasses will be available on NET-A-PORTER with each pair enabling consumers to help protect dedicated remote islands (waitlist opens May 17 on CleanWaves.com). Individual geographical coordinates are featured on every pair of eyewear, directly connecting each pair to a specific place in paradise impacted by marine plastic pollution and through purchase consumers help protect. For every 100 pairs of sunglasses sold, Parley and Corona will expand their commitment and protect one more island against marine plastic pollution for one year. The first edition launches with models linking to islands in Maldives, Palau and Bali.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180516006620/en/

Clean Waves (Photo: Business Wire)

Clean Waves (Photo: Business Wire)

Since making a commitment to protect 100 islands by 2020, Corona x Parley have intercepted plastic from dozens of remote islands, while rallying thousands of volunteers for clean-ups and education campaigns. The material collected sparked a deeper investigation into the complex types, sources and pathways of plastic in some of the most severely affected areas of the Maldives, Indonesia, Australia, Sri Lanka, Mexico and Chile. The launch of Clean Waves will bring new value to such plastic waste intercepted by upcycling the full range of plastic types, including some that are typically overlooked or left behind due to low material value. Therefore, in addition to the most valuable recyclables, including PET, Nylon 6 and HDPE, Clean Waves is also putting a strong focus on transforming polypropylene (PP) into new forms of Ocean Plastic® for use in high-end consumer products, starting with fashion accessories. The sunglasses are the first produced with a new technology, which transforms low-quality types of plastic waste into high-performance materials, providing a unique look.

“Plastic is everywhere, a design failure which harms sea life and human health. While we can’t phase it out overnight, we can stop making more. Clean Waves is the urgently needed fundraising platform where creators support our movement by designing products from Ocean Plastic®, a premium material made from upcycled marine plastic debris,” said Cyrill Gutsch, founder of Parley for the Oceans.

Clean Waves will include collaborations from industry leaders in fashion, industrial design, photography, art, film, music and material science who are equally passionate about the health of our oceans and the development of less harmful, and ultimately non-harmful ways of designing, making and using products.

“As a brand that calls the beach home, Corona has a long-term mission to address the problem of marine plastic pollution and ultimately protect paradise. Over the years, we’ve conducted many clean-ups and most recently committed to protect 100 islands by 2020 with Parley,” said Felipe Ambra, Global VP of Corona. “Yet, with approximately eight million metric tons of plastic being dumped into the ocean each year, we recognize that the problem is bigger than any one island and the creation of Clean Waves is a way for other ocean warriors to support upcycling and help us build on our existing commitment.”

Clean Waves launches with a first product crafted in Italy: limited edition sunglasses that will be available for purchase exclusively on NET-A-PORTER with a waitlist opening May 17 on CleanWaves.com. Prices range from $300-320 USD with 100% of the proceeds supporting the cause. The first Clean Waves sunglasses launch with three models in the Archetype series:

  • Archetype I - White Flag: solid white frame with mirror lenses, funding the protection of one island in the Maldives ($300)
  • Archetype I - Coral Sand: multicolored frame with mirrored lenses, funding the protection of one island near Bali ($320)
  • Archetype I - Reef Camo: multicolored frame with mirrored lenses, funding the protection of one island in Palau. ($320)

About Corona x Parley
In May 2017, Corona and Parley for the Oceans announced their alliance and made a commitment to protect 100 islands by 2020. The protection of 100 islands is made possible through the implementation of the Parley AIR Strategy: Avoid, Intercept, Redesign. The first year of the Corona x Parley partnership focused on working with local communities to “avoid” plastic use and “intercept” it from shorelines before it enters the ocean. With approximately eight million metric tons of plastic entering the ocean each year, it is of equal importance to “redesign” the uses, sources and systems behind plastic pollution, not only collect it.

The partnership has already had an impact in several regions around the world. Over 25 islands are now under protection in the Maldives with new islands in Australia, Chile, Dominican Republic and Indonesia to be announced. The project led to the first virgin-plastic free World Surf League (WSL) event in South Africa, Jeffrey’s Bay last July and most recently, resulted in a series of clean-ups down the cost of Chile led by big wave surfer and activist, Ramon Navarro.

For additional information on the partnership and 100 Islands Project, visit CoronaXParley.com

About Parley for the Oceans
Parley for the Oceans is the global network where creators, thinkers and leaders from the creative industries, brands, governments and environmental groups come together to raise awareness for the beauty and fragility of the oceans and collaborate on projects that can end their destruction. The organization has formed alliances with major corporations including adidas, Anheuser Busch InBev (Corona), Intel; the United Nations; the Maldives and collaborators spanning the worlds of science, art, fashion, design, entertainment, sports, and space and ocean exploration. To know more: www.parley.tv

About Ocean Plastic®
Parley understands current plastic is a design failure, seeing the long-term solution for marine plastic pollution in the redesign of the harmful material. In the meantime, Parley created a catalyst innovation that provides an immediate replacement for new, virgin plastic: Ocean Plastic®, a range of premium materials created from upcycled plastic waste intercepted from oceans, shorelines, and in coastal communities. Together with its partners, in the last five years Parley raised awareness for the issue, boosted the general image of recycling and established the first global supply chain for marine plastic debris. Additionally, Parley created a funding mechanism that financially allows the implementation of the Parley AIR Strategy in four key areas: Communication and Education, Direct Impact, Research and Development, and Eco-Innovation.

About Corona
Born in Mexico, Corona is the leading beer brand in the country, the most popular Mexican beer worldwide exported to more than 180 countries. Corona Extra was first brewed in 1925 at the Cervecería Modelo in Mexico City and is still proudly produced entirely in Mexico.

Corona is a pioneer in the beer industry by being the first to use a transparent bottle showcasing its purity and high quality to the world. Each glass bottle is produced in a glass factory in Mexico owned by the brand. The artwork found on the bottle is painted, highlighting our commitment to quality in our packaging and our Mexican heritage.

No Corona is complete without the lime. Naturally adding character, flavor and refreshment, the lime ritual is an integral part of delivering an experience that is truly unique to Corona. The brand is synonymous with the beach and celebrates time outdoors. It invites people to pause, relax and enjoy the simple pleasures of life. For more visit www.corona.com

Contact information

Media
Anheuser-Busch InBev/Corona:
Evan Ellman
Evan.Ellman@ab-inbev.com
or
Alison Brod Marketing + Communications:
Alyssa Ahern, +1 212-230-1800
Corona@alisonbrodmc.com
or
Parley for the Oceans:
Silvia Raccagni
silvia@parley.tv

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

FDA Approves OTEZLA® (apremilast) for the Treatment of Oral Ulcers Associated with Behçet’s Disease19.7.2019 17:59:00 CESTPress release

Celgene Corporation (NASDAQ:CELG) today announced that the U.S. Food and Drug Administration (FDA) has approved OTEZLA® (apremilast) 30 mg twice daily (BID) for the treatment of adult patients with oral ulcers associated with Behçet’s Disease. OTEZLA, an oral, selective inhibitor of phosphodiesterase 4 (PDE4), is the first and only approved treatment option for oral ulcers associated with Behçet’s Disease, a rare, chronic, multisystem inflammatory disease that is difficult to treat. “Oral ulcers are a recurring and debilitating manifestation that affects nearly everyone living with Behçet’s Disease, and have an important negative impact on the quality of life for these patients,” said Yusuf Yazici, M.D., Clinical Associate Professor, Department of Medicine, New York University Langone Health. “In the clinical trial, OTEZLA demonstrated improvements in measures of oral ulcers at week 12. OTEZLA has the potential to be a needed treatment option for U.S. patients and their physicians, who

Abiraterone Acetate Included in World Health Organisation’s Essential Medicines List for the Treatment of Metastatic Castration-Resistant Prostate Cancer19.7.2019 13:05:00 CESTPress release

The Janssen Pharmaceutical Companies of Johnson & Johnson is delighted with the recent announcement from the World Health Organisation (WHO) to include abiraterone acetate (ZYTIGA ® ) for the treatment of metastatic castration-resistant prostate cancer (mCRPC), in the updated Essential Medicines List, published on 9th July 2019.1,2 The WHO’s Essential Medicines List is a core guidance document that helps countries prioritise critical health products that are recommended to be widely available and affordable throughout health systems.1 “The inclusion of abiraterone acetate in the WHO Essential Medicines List highlights the critical role that this treatment can play in improving the lives of patients living with mCRPC and their families,” said Dr. Joaquín Casariego, Janssen Therapeutic Area Lead Oncology for Europe, Middle East & Africa, Janssen-Cilag S.A. “I am proud that we are working hard to impact survival and quality of life by developing and providing innovative medicines which ar

Gilead Sciences Licenses Respiratory and Herpes Antiviral Research Programs From Novartis19.7.2019 12:30:00 CESTPress release

Gilead Sciences, Inc. (NASDAQ: GILD) announced today that it has licensed three preclinical antiviral programs from Novartis, including investigational agents with the potential to treat human rhinovirus, influenza and herpes viruses. Under the agreement, Gilead will acquire exclusive global rights to develop and commercialize novel small molecules against three undisclosed targets. Novartis will receive an upfront payment and is eligible to receive up to an additional $291 million in potential milestone payments upon achievement of certain development and commercial milestones, as well as royalties on annual net sales. “Today’s announcement builds on Gilead’s heritage in antiviral research and development. We look forward to applying this expertise to advance the development of potential new treatments for viruses with limited therapeutic options,” said John McHutchison AO, MD, Gilead’s Chief Scientific Officer and Head of Research and Development. Gilead’s antiviral portfolio include

Schlumberger Announces Second-Quarter 2019 Results19.7.2019 11:00:00 CESTPress release

Schlumberger Limited (NYSE: SLB) today reported results for the second quarter of 2019. (Stated in millions, except per share amounts) Three Months Ended Change Jun. 30, 2019 Mar. 31, 2019 Jun. 30, 2018 Sequential Year-on-year Revenue $8,269 $7,879 $8,303 5% 0% Pretax segment operating income $968 $908 $1,094 7% -12% Pretax segment operating margin 11.7% 11.5% 13.2% 17 bps -148 bps Net income - GAAP basis $492 $421 $430 17% 14% Net income, excluding charges & credits* $492 $421 $594 17% -17% Diluted EPS - GAAP basis $0.35 $0.30 $0.31 17% 13% Diluted EPS, excluding charges & credits* $0.35 $0.30 $0.43 17% -19% North America revenue $2,801 $2,738 $3,139 2% -11% International revenue $5,463 $5,037 $5,065 8% 8% North America revenue, excluding Cameron $2,243 $2,178 $2,546 3% -12% International revenue, excluding Cameron $4,761 $4,469 $4,387 7% 9% *These are non-GAAP financial measures. See section titled "Charges & Credits" for details. Schlumberger Chairman and CEO Paal Kibsgaard commente

Schlumberger Appoints Olivier Le Peuch as CEO19.7.2019 10:46:00 CESTPress release

Schlumberger Limited (NYSE: SLB) announced today that its Board of Directors has appointed Olivier Le Peuch as its Chief Executive Officer and member of the Schlumberger Board, effective August 1, 2019. Mr. Le Peuch succeeds Paal Kibsgaard, who will retire as Chief Executive Officer effective that same date. Also effective August 1, Mr. Kibsgaard will step down as Chairman of the Board and retire as a member of the Board of Directors. Mr. Kibsgaard will retire after more than 22 years of service to the Company, including eight years as CEO and four years as Chairman. Effective the same date, Mark G. Papa, a current non-independent director, will become non-executive Chairman of the Board. Peter Currie will continue to serve as the Board’s Lead Independent Director. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190719005161/en/ Olivier Le Peuch is appointed Chief Executive Officer and a member of the Schlumberger Board, effe

Fluke Corporation Acquires Industrial Reliability Leader PRÜFTECHNIK19.7.2019 10:00:00 CESTPress release

Fluke Corp., the global leader in test and measurement instruments, has acquired Ismaning, Germany-based PRÜFTECHNIK, a market leader in precision laser shaft alignment, condition monitoring, and non-destructive testing. “Fluke’s acquisition of PRÜFTECHNIK reflects the growing importance our customers place on reliability systems to keep their equipment in optimum operating condition,” said Marc Tremblay, president of Fluke Corporation. “This business will help us usher in the next generation of solutions for our industrial customers.” Fluke Corporation For information on Fluke tools and applications, or to find the location of your nearest distributor, contact Fluke Corporation, P.O. Box 9090, Everett, WA USA 98206, call (800) 44-FLUKE (800-443-5853), fax (425) 446-5116, e-mail fluke-info@fluke.com or visit the Fluke Web site at http://www.fluke.com. About Fluke Founded in 1948, Fluke Corporation is the world leader in compact, professional electronic test tools and software for measu